Purchases and Sales Made in Q4 2023 in Collegium Pharmaceutical, Inc (COLL)
This table provides information about the institutional ownership of Collegium Pharmaceutical, Inc (COLL) during Q4 2023. The information is specifically focused on institutions that hold shares of COLLEGIUM PHARMACEUTICAL, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 05, 2024
Q4 2023
|
Emerald Advisers, LLC
|
SELL
|
- |
-24.4K- 3.53% |
$516K - $751K
|
666K
$21.7M
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-25K- 3.34% |
$528K - $769K
|
723K
$23.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-26.3K- 1.12% |
$557K - $810K
|
2.31M
$75.4M
|
|
|
Feb 06, 2024
Q4 2023
|
Natixis Advisors, L.P.
Boston, MA |
SELL
|
- |
-26.5K- 48.7% |
$560K - $815K
|
27.9K
$909K
|
|
|
Feb 09, 2024
Q4 2023
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-38.4K- 28.88% |
$813K - $1.18M
|
94.6K
$3.08M
|
|
|
Feb 09, 2024
Q4 2023
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-42.9K- 46.9% |
$908K - $1.32M
|
48.6K
$1.58M
|
|
|
Feb 09, 2024
Q4 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-44.2K- 53.49% |
$934K - $1.36M
|
38.4K
$1.25M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-51.5K- 18.56% |
$1.09M - $1.58M
|
226K
$7.36M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-64K- 20.71% |
$1.35M - $1.97M
|
245K
$7.98M
|
|
|
Jan 17, 2024
Q4 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-79.8K- 18.75% |
$1.69M - $2.46M
|
346K
$11.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-89.2K- 25.56% |
$1.89M - $2.75M
|
260K
$8.47M
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-111K- 87.4% |
$2.35M - $3.42M
|
16K
$521K
|
|
|
Jan 26, 2024
Q4 2023
|
Peregrine Capital Management LLC
|
SELL
|
- |
-115K- 24.97% |
$2.43M - $3.53M
|
345K
$11.2M
|
|
|
Feb 12, 2024
Q4 2023
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-149K- 51.31% |
$3.15M - $4.58M
|
141K
$4.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-211K- 49.05% |
$4.47M - $6.5M
|
219K
$7.15M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-250K- 64.78% |
$5.3M - $7.71M
|
136K
$4.43M
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-253K- 28.71% |
$5.35M - $7.78M
|
628K
$20.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-417K- 13.13% |
$8.82M - $12.8M
|
2.76M
$89.9M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-454K- 7.27% |
$9.61M - $14M
|
5.79M
$189M
|